One-year outcomes and secondary prevention in patients after acute minor stroke: results from the China National Stroke Registry

Neurological Research

Volumn 39, Issue 6, 2017, Pages 484-491

  Tan, Ying ^a,b   Pan, Yuesong ^a,b   Liu, Liping ^a,b   Wang, Yilong ^a,b   Zhao, Xingquan ^a,b   Wang, Yongjun ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

Author keywords

acute phase; Minor ischemic stroke; outcomes; secondary prevention; stroke recurrence

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; APHASIA; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISABILITY; DISEASE DURATION; DYSARTHRIA; FACIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PERIODIC LIMB MOVEMENT DISORDER; PROPHYLAXIS; RANKIN SCALE; RECURRENT DISEASE; REGISTER; RELAPSE; RISK FACTOR; SECONDARY PREVENTION; TRANSIENT ISCHEMIC ATTACK; ACUTE DISEASE; BRAIN ISCHEMIA; CHINA; COMPLICATION; EPIDEMIOLOGY; MIDDLE AGED; PROCEDURES; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CHINA; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; SECONDARY PREVENTION; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 85018251116     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1080/01616412.2017.1322804     Document Type: Article

References (28)

1. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990–2010:findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245–255.10.1016/S0140-6736(13)61953-4
2. Liu M, Wu B, Wang WZ, et al. Stroke in China:epidemiology, prevention, and management strategies. Lancet Neurol. 2007;6:456–464.10.1016/S1474-4422(07)70004-2
3. Coull AJ, Lovett JK, Rothwell PM, Oxford Vascular Study. Population based study of early risk of stroke after transient ischaemic attack or minor stroke:implications for public education and organisation of services. BMJ. 2004;328:326.10.1136/bmj.37991.635266.44
4. Atanassova PA, Chalakova NT, Dimitrov BD. Major vascular events after transient ischaemic attack and minor ischaemic stroke:post hoc modelling of incidence dynamics. Cerebrovasc Dis. 2008;25:225–233.10.1159/000113860
5. Lavallee PC, Meseguer E, Abboud H, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA):feasibility and effects. Lancet Neurol. 2007;6:953–960.10.1016/S1474-4422(07)70248-X
6. Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study):a prospective population-based sequential comparison. Lancet. 2007;370:1432–1442.10.1016/S0140-6736(07)61448-2
7. Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369:11–19.10.1056/NEJMoa1215340
8. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160–2236.10.1161/STR.0000000000000024
9. Ji R, Liu G, Shen H, et al. Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population:data from China National Stroke Registry. Neurol Res. 2013;35:29–36.10.1179/1743132812Y.0000000107
10. Wei JW, Wang JG, Huang Y, Liu M, Wu Y, Wong LK, et al. Secondary prevention of ischemic stroke in urban China. Stroke. 2010;41:967–974.10.1161/STROKEAHA.109.571463
11. Wang Y, Cui L, Ji X, et al. The China National Stroke Registry for patients with acute cerebrovascular events:design, rationale, and baseline patient characteristics. Int J Stroke. 2011;6:355–361.10.1111/j.1747-4949.2011.00584.x
12. Khatri P, Kleindorfer DO, Yeatts SD, et al. Strokes with minor symptoms:an exploratory analysis of the national institute of neurological disorders and stroke recombinant tissue plasminogen activator trials. Stroke. 2010;41:2581–2586.10.1161/STROKEAHA.110.593632
13. Yu AY, Hill MD, Coutts SB. Should minor stroke patients be thrombolyzed? A focused review and future directions. Int J Stroke. 2015;10:292–297.10.1111/ijs.12426
14. Johnston SC, Amarenco P, Albers GW, et al. Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med. 2016;375:35–43.10.1056/NEJMoa1603060
15. Coull AJ, Lovett JK, Rothwell PM. Population based study of early risk of stroke after transient ischaemic attack or minor stroke:implications for public education and organisation of services. BMJ. 2004;328:326.10.1136/bmj.37991.635266.44
16. Ois A, Gomis M, Rodriguez-Campello A, et al. Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke. Stroke. 2008;39:1717–1721.10.1161/STROKEAHA.107.505438
17. Amarenco P, Lavallee PC, Labreuche J, Albers GW, Bornstein NM, Canhao P, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med. 2016;374:1533–1542.10.1056/NEJMoa1412981
18. Ovbiagele B, Saver JL, Fredieu A, et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke. 2004;35:2879–2883.10.1161/01.STR.0000147967.49567.d6
19. Olson DM, Cox M, Pan W, et al. Death and rehospitalization after transient ischemic attack or acute ischemic stroke:one-year outcomes from the adherence evaluation of acute ischemic stroke–longitudinal registry. J Stroke Cerebrovasc Dis. 2013;22:e181–e188.10.1016/j.jstrokecerebrovasdis.2012.11.001
20. Group ES, Halkes PH, van Gijn J, Kappelle LJ, et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (esprit):Randomised controlled trial. Lancet. 2006;367:1665–1673.
21. Kennedy J, Hill MD, Ryckborst kJ, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER):a randomised controlled pilot trial. Lancet Neurol. 2007;6:961–969.10.1016/S1474-4422(07)70250-8
22. Halkes PH, Gray LJ, Bath PM, et al. Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke:a meta-analysis by risk. J Neurol Neurosurg Psychiatry. 2008;79:1218–1223.10.1136/jnnp.2008.143875
23. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation:A systematic review. Neurology. 2007;69:546–554.
24. Hill MD, Yiannakoulias N, Jeerakathil T, et al. The high risk of stroke immediately after transient ischemic attack:a population-based study. Neurology. 2004;62:2015–2020.10.1212/01.WNL.0000129482.70315.2F
25. Wu L, Wang A, Wang X, et al. Factors for short-term outcomes in patients with a minor stroke:results from China National Stroke Registry. BMC Neurol. 2015;15:456.10.1186/s12883-015-0505-z
26. David Spence J. Recent advances in atrial fibrillation and stroke. Neurol Res. 2015;37:381–384.10.1179/1743132815Y.0000000026
27. Wang C, Yang Z, Wang C, et al. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation:results from the China National Stroke Registry. J Stroke Cerebrovasc Dis. 2014;23:1157–1163.10.1016/j.jstrokecerebrovasdis.2013.10.006
28. Park JH, Ovbiagele B. Optimal combination secondary prevention drug treatment and stroke outcomes. Neurology. 2015;84:50–56.10.1212/WNL.0000000000001099